Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy
- PMID: 7573039
- PMCID: PMC1801497
Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy
Abstract
DNA studies in 103 spinal muscular atrophy (SMA) patients from The Netherlands revealed homozygosity for a survival motor neuron (SMN) deletion in 96 (93%) of 103. Neuronal apoptosis inhibitory protein deletions were found in 38 (37%) of 103 and occurred most frequently in SMA type I. SMN deletions have not yet been described to occur in healthy subjects. In this study, however, four unaffected sibs from two SMA families showed homozygosity for SMN deletions. Homozygosity for an SMN deletion in unaffected persons seems to be very rare. Therefore, demonstration of a homozygous SMN deletion in a clinically presumed SMA patient should be considered as a confirmation of the diagnosis, whether or not SMN is in fact the causal gene for SMA.
Similar articles
-
Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.Hum Mol Genet. 1995 Oct;4(10):1927-33. doi: 10.1093/hmg/4.10.1927. Hum Mol Genet. 1995. PMID: 8595417
-
Molecular analysis of survival motor neuron (SMN) and neuronal apoptosis inhibitory protein (NAIP) genes of spinal muscular atrophy patients and their parents.Hum Genet. 1997 Oct;100(5-6):577-81. doi: 10.1007/s004390050555. Hum Genet. 1997. PMID: 9341874
-
Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients.Neurol India. 2006 Sep;54(3):255-9. doi: 10.4103/0028-3886.27147. Neurol India. 2006. PMID: 16936383
-
[Molecular genetic diagnosis and deletion analysis in Type I-III spinal muscular atrophy].Schweiz Med Wochenschr. 1996 May 25;126(21):907-14. Schweiz Med Wochenschr. 1996. PMID: 8693311 Review. German.
-
Spinal muscular atrophy--clinical and genetic correlations.Neuromuscul Disord. 1997 May;7(3):202-7. doi: 10.1016/s0960-8966(97)00459-8. Neuromuscul Disord. 1997. PMID: 9185186 Review.
Cited by
-
The Identification of Novel Biomarkers Is Required to Improve Adult SMA Patient Stratification, Diagnosis and Treatment.J Pers Med. 2020 Jul 29;10(3):75. doi: 10.3390/jpm10030075. J Pers Med. 2020. PMID: 32751151 Free PMC article. Review.
-
Balanced translocation t(4q; 10q) in infantile spinal muscular atrophy.Eur J Pediatr. 1997 Nov;156(11):896-7. doi: 10.1007/BF03260102. Eur J Pediatr. 1997. PMID: 9392413 No abstract available.
-
Drug treatment for spinal muscular atrophy type I.Cochrane Database Syst Rev. 2019 Dec 11;12(12):CD006281. doi: 10.1002/14651858.CD006281.pub5. Cochrane Database Syst Rev. 2019. PMID: 31825542 Free PMC article.
-
Spinal muscular atrophy: development and implementation of potential treatments.Ann Neurol. 2013 Sep;74(3):348-62. doi: 10.1002/ana.23995. Ann Neurol. 2013. PMID: 23939659 Free PMC article. Review.
-
Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy.J Neurodegener Dis. 2013;2013:903875. doi: 10.1155/2013/903875. Epub 2013 Mar 24. J Neurodegener Dis. 2013. PMID: 26317002 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical